Datasets from GEO also demonstrated that UBC9 was significantly increased in bladder cancer samples (P = 3.92 × 10–4 for GSE3167, P = 0.003 for GSE13507, P = 0.002 for GSE19915) (Fig. 1A). This evidence concerns the gene UBE2I and urinary bladder cancer.